common side effects of emsam
application site reaction
insomnia
other side effects
skin rash
weight loss
orthostatic hypotension
comprehensive list of adverse effects
prospective pre-marketing studies
reported side effects
treatment discontinuation with selegiline
active ingredient
emsam
oral tablets
decreasing order of frequency
nausea
hallucinations
confusion
depression
loss of balance
insomnia
orthostatic hypotension
akinetic involuntary movements
agitation
arrhythmia
bradykinesia
chorea
delusions
hypertension
increased angina pectoris
syncope
clinical trials with selegiline
disintegrating tablets
reported side effects
treatment discontinuation
dizziness
chest pain
accidental injury
myasthenia
relative risk for treatment-emergent hypertension
postural hypotension
being at least fold greater in patients years
years
patients over years
increased risk for somnolence
younger patients
clinical trials with selegiline
transdermal patches
application site reaction
side effect
treatment discontinuation
patients at a rate at least
placebo
selegiline
effects of levodopa
side effects of levodopa
levodopa dose
insomnia
disorder
common side effects with selegiline
active ingredient
emsam
double-blind placebo-controlled clinical trials at a higher frequency
adjunctive therapy with levodopa in the earlier phases of parkinson
disease
insomnia
common side effect in placebo-controlled clinical trials for major depressive disorder with transdermal selegiline
parkinson
disease patients
dopamine agonists
other dopaminergic treatments
selegiline
exhibiting impulse control disorders
pathological gambling
libido
hypersexuality
compulsive spending/buying
binge eating
few cases
selegiline
cases
dose reduction
treatment discontinuation
cessation of impulse control disorders
postmarketing reports
patients
drug
worsening
worsening mental status
behavioral changes
psychotic-like behavior
starting therapy
increasing
dose
certain medications
psychosis
dopamine antagonists
symptoms of parkinson
disease
effectiveness of selegiline
bruxism
doses
mg per day
anxiety
common side effect with selegiline in double-blind placebo-controlled clinical trials
adjunctive therapy with levodopa in the earlier phases of parkinson
disease
antidepressants
role
inducing worsening of depression
emergence of suicidality in certain patients during the early phases of treatment
increased risk of suicidal thinking
behavior in children
adolescents
young adults
years
major depressive disorder
mdd
other psychiatric disorders
short-term use of antidepressant drugs
adult
pediatric patients
receiving antidepressants for mdd
nonpsychiatric indications
reported symptoms
precursors
emerging suicidality
including anxiety
agitation
panic attacks
insomnia
irritability
hostility
aggressiveness
impulsivity
akathisia
hypomania
mania
causality
insomniacommon
anxiety/tension
confusion
depression
euphoria
hallucinations
illusion
sleeping disorders
vivid dreamsuncommon
abnormal dreams
agitation
manic reaction
mild transient irritability
mood change
psychosesfrequency
apathy
delusions
disorientation
dreams/nightmares
hollow feeling
overstimulation
personality change
sleep disturbance
transient irritabilitypostmarketing reports
abnormal thinking
aggressive reaction
bruxism
delirium
impulse control disorders
compulsions
nervousness
paranoid reaction
paroniria
psychotic-like behavior
dizziness/lightheadedness/faintingcommon
abnormal movements
dyskinesias
bradykinesia
akinesia
ataxia
headache
impaired balance
lethargy
somnolence
syncope
tremorfrequency
chorea
drowsiness
dyskinesia
dystonic symptoms
festination
impaired memory
apraxia
involuntary movements
migraine
myoclonic jerks
numbness of toes/fingers
restlessness
speech
supraorbital pain
tardive dyskinesiapostmarketing reports
abnormal gait
cerebrovascular disorder
coma
convulsions
hypertonia
involuntary muscle contractions
neuroleptic malignant syndrome
serotonin syndrome
taste disturbance
been reports
falling
activities of daily living
including
operation of motor vehicles
accidents
parkinson
disease patients
drug
reports
setting of pre-existing somnolence
impaired memory
myoclonic jerks
doses
mg per day
seizure in dialyzed chronic renal failure in a patient
selegiline on concomitant medications
postmarketing experience
symptom complex
neuroleptic malignant syndrome
other obvious etiology
association with rapid dose reduction
withdrawal
changes
antiparkinson therapy
been postmarketing reports of fatal
non-fatal cases of serotonin syndrome with concomitant use of this drug with antidepressants
headache
common side effect in placebo-controlled clinical trials for major depressive disorder with transdermal selegiline
drug
catabolism of dietary amines
tyramine
hypertensive crisis
ingestion of tyramine-rich foods
beverages
postural hypotension
selegiline
active ingredient
emsam
double-blind placebo-controlled clinical trials at a higher frequency
adjunctive therapy with levodopa in the earlier phases of parkinson
disease
late phase
palpitation
common side effect in the earlier phases of parkinson
disease in these trials
postural hypotensioncommon
arrhythmia
bradycardia
chest pain
hypertension
hypotension
edema
palpitationsuncommon
angina
ankle edema
orthostatic hypotension
supraventricular tachycardiafrequency
peripheral edema
hematoma
tachycardiapostmarketing reports
flushing
myocardial infarction
constipation
common side effect with selegiline
active ingredient
emsam
double-blind placebo-controlled clinical trials
adjunctive therapy with levodopa in the earlier phases of parkinson
disease
dry mouth
irritation of the buccal mucosa
disintegrating tablet
mouth ulceration
nausea
stomatitiscommon
abdominal pain
constipation
diarrhea
dyspepsia
dysphagia
eructation
flatulence
gastric irritation
tooth disorder
vomitingfrequency
gastrointestinal bleeding
exacerbation of pre-existing ulcer disease
heartburn
rectal bleeding
throat burning
increased energy
doses
mg per day
vertigo
common side effect
selegiline
active ingredient
emsam
double-blind placebo-controlled clinical trials
adjunctive therapy with levodopa
use as monotherapy
fatiguecommon
fall
pain
vertigofrequency
chills
generalized ache
falling
freezing
heavy leg
energy
malaise
tinnitus
tiredness
weaknesspostmarketing reports
asthenia
death
fever
rashcommon
ecchymosis
sweating
skin disordersuncommon
hair loss
skin eruptionsfrequency
facial hair
photosensitivity
skin disorders
drug
skin ulcer
fungal dermatitis
skin hypertrophy
contact dermatitis
herpes simplex
dry skin
sweating
urticaria
pruritus
micturition disordercommon
urinary retentionfrequency
hypersexuality
nocturia
penile sensation
prostatic hypertrophy
sexual dysfunction
slow urination
transient anorgasmia
urinary frequency
urinary hesitancypostmarketing reports
increased libido
transient anorgasmia
penile sensation
doses
mg per day
estimates of the incidence of untoward sexual experience
performance
actual incidence
patients
physicians
issue
leucocytopenia
thrombocytopenia
alt/ast increaseduncommon
transient increase in liver enzyme values
application site reactions
transdermal patch
application site reactions with the transdermal patch
erythema
treatment
mg
disintegrating tablet
mg phenylalanine
anorexia
common side effect with selegiline
active ingredient
emsam
double-blind placebo-controlled clinical trials
adjunctive therapy with levodopa in the earlier phases of parkinson
disease
anorexiacommon
hypokalemia
weight lossuncommon
loss of appetitepostmarketing reports
hyperglycemia
hypoglycemia
muscle
doses
mg per day
arthralgia
pain
leg cramps
leg pain
pain
myalgia
musculoskeletal injuries
muscle crampsuncommon
myopathyfrequency
muscle
stiff neckpostmarketing reports
muscle weakness
myasthenia
abnormal accommodationuncommon
blurred visionfrequency
blepharospasm
diplopiapostmarketing reports
abnormal vision
frequency
melanoma
epidemiological studies
parkinson
disease patients
fold
risk
developing melanoma than the general population
observed increase in risk
parkinson
disease
other factors
small increments in serum bun
creatinine
high doses
disintegrating selegiline
active ingredient
emsam
mg
day
frequency
small increments in serum bun
creatinine
dyspnea
hiccup
nasal congestion
pharyngitis
rhinitis
sinusitis
sore throatfrequency
asthma
transdermal patch
release
twitching
twisting
uncontrolled repetitive movements of the tongue
lips
face
arms
legs
blurred vision
bruising
chest pain
convulsions
decreased urine
breathing
difficulty with swallowing
discouragement
dizziness
dry mouth
feeling
headache
increased thirst
irregular heartbeat
irritability
purplish patches in the skin
loss of appetite
loss of interest
pleasure
mood changes
muscle pain
cramps
nausea or vomiting
nervousness
numbness
tingling in the hands
feet
lips
pounding in the ears
seeing
hearing
feeling things
shakiness
unsteady walk
shakiness in the legs
arms
hands
feet
sleepiness
unusual drowsiness
fast heartbeat
swelling
inflammation of the mouth
tightness in the chest
tiredness
trouble concentrating
trouble sleeping
unsteadiness
trembling
other problems with muscle control
coordination
unusual tiredness
weakness
agitation
diarrhea
dizziness
faintness
lightheadedness
getting
lying
sitting position
fever
overactive reflexes
poor coordination
restlessness
shivering
sweating
talking
acting with excitement
agitation
chest pain
difficulty
mouth
lockjaw
dizziness
fainting
irregular pulse
continuing
high fever
low blood pressure
severe spasm
head
heels
body
troubled breathing
dry skin 
hives
itching
skin rash
itching
scaling
severe redness
soreness
swelling of the skin
runny nose
sneezing
stuffy nose
trouble sleeping
acid
sour stomach
back pain
belching
full feeling
body aches
pain
congestion
cough
difficulty
bowel movement
stool
difficulty with moving
dryness
soreness of the throat
excess air
gas in the stomach
intestines
heartburn
hoarseness
indigestion
joint pain
leg cramps
muscle
cramping
muscle pains
stiffness
passing gas
stomach discomfort
pain
swollen joints
tender
swollen glands in the neck
tooth problems
voice changes